Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872162 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusion: After prostatectomy, favorable-group patients may fare well with salvage radiotherapy alone. These patients may be spared the toxicity of androgen ablation. The other patients may benefit most from a combined approach with hormonal treatment. We further suggest that salvage radiotherapy should be given early when the PSA is still low.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rex M.D., Ph.D., Ashish M. M.D., Renaud M.D., Pamela K. M.P.H., Andrew K. M.D., M.P.H., Susan L. Ph.D., Louis M.D., Richard J. M.D., Deborah M.D.,